Typhoid vaccine cell; surface purified Vi polysaccharide 25micrograms per 0.5mL; soln; for IM inj; contains phenol. An increase in serum anti-capsular antibodies is thought to be the basis of ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
LONDON (Reuters) Oct 09 - Sanofi Pasteur MSD, the vaccine joint venture of Sanofi and Merck & Co, has recalled some batches of its typhoid vaccine because of concerns about effectiveness, Britain's ...
Sanofi Pasteur, the vaccines division of Sanofi announced that the World Health Organization (WHO) has granted pre-qualification to its Typhim Vi polysaccharide typhoid vaccine. Typhim Vi is the first ...
A vaccine maker is recalling batches of typhoid fever vaccine that may not be potent enough. Health Canada said Thursday that Sanofi Pasteur is recalling batches of the Typhim Vi vaccine. The Typhim ...
W związku z bezpłatną subskrypcją zgadzam się na otrzymywanie na podany adres email informacji handlowych. Informujemy, że dane przekazane w związku z zamówieniem newslettera będą przetwarzane zgodnie ...
More than 700,000 people who thought they were protected against typhoid may be vulnerable to the disease, because of a dud batches of a vaccine. By Stephen Adams and Stephenadams 08 October 2012 • ...
The full CMI on the next page has more details. If you are worried about using this medicine, speak to your doctor or pharmacist. Typhim Vi contains the active ingredient salmonella typhi Vi ...
The information provided on this page is intended to serve as a comprehensive resource and should not be a substitute to professional medical advice. If you have concerns it is always best to speak ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results